Citation Impact
Citing Papers
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Anti-cancer natural products isolated from chinese medicinal herbs
2011 Standout
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifs
2008
Acromegaly
2006 Standout
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
2005
Advances and challenges in targeting FGFR signalling in cancer
2017
Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion
2014
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
Extracellular matrix structure
2015 Standout
Breaking the chains: structure and function of the deubiquitinases
2009 Standout
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Lumican affects tumor cell functions, tumor–ECM interactions, angiogenesis and inflammatory response
2013
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Lumican expression is positively correlated with the differentiation and negatively with the growth of human osteosarcoma cells
2007
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Targeting ubiquitin specific proteases for drug discovery
2007
Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma
2007
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Protein partners of deubiquitinating enzymes
2008
FGF8 promotes colorectal cancer growth and metastasis by activating YAP1
2014
FGF Receptors: Cancer Biology and Therapeutics
2013
Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b
2008
The extracellular matrix at a glance
2010 Standout
Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
2015
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
Chemoprevention of Intestinal Tumorigenesis in APCmin/+ Mice by Silibinin
2010
Works of Tomoko Seya being referenced
Fibroblast Growth Factor Receptor 2 IIIc as a Therapeutic Target for Colorectal Cancer Cells
2012
Establishment and Characterization of Two New Rectal Neuroendocrine Cell Carcinoma Cell Lines
2000
Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer
2011
Antiangiogenic Effect of Octreotide Inhibits the Growth of Human Rectal Neuroendocrine Carcinoma
2002
Different expression levels of lumican in human carcinoid tumor and neuroendocrine cell carcinoma
2005
Identification of neovasculature using nestin in colorectal cancer
2007
Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases
2006
Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis
2006